Health knowledge made personal
WellPage for Indication For Anticoagulation
+ Bookmark › Share
Go
Search posts:

Indication For Anticoagulation - Articles

AHA Press release on PFO: More patients needed in clinical trials to find treatment for heart condition linked to certain stroke by David D. Patient ExpertHealth Maven Posted Tue 12 May 2009 3:27pm  Article source: American Heart Association media room   News Releases More patients needed in clinical trials to find treatment for heart condition linked to certain strokes Statement Highlights: Patent foramen ovale (PFO), an opening between the two chambers of the heart, has been associated with some strokes for which the ... Read on »
What are the mechanisms of “Pulmonary Arterial Hypertension” in Dilated cardiomyopathy ? by Dr. Sangareddi V. Medical Doctor Posted Sat 18 Feb 2012 10:13am Pulmonary  arterial hypertension (PAH ) is  an uncommon manifestation of dilated cardiomyopathy .While pulmonary venous hypertension of some degree is expected in most patients with DCM,  it is rare for these patients to go for severe arterial hypertension. The reason for this may be the  natural history of DCM do not allow these patients t ... Read on »
Deep vein thrombosis : Therapeutic dilemmas by Dr. Sangareddi V. Medical Doctor Posted Wed 29 Apr 2009 10:59pm The importance of venous system Cardiovascular system  consists  not only of  heart  but also   the blood delivery and retrieval   system namely  the arterial and venous circulation .As  the heart pumps , 6  liters   of blood  every minute  , it  has to   traverse the  entire venous circulation promptly ,  to  complete  the hemodynamic cir ... Read on »
Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Ovarian Adnexal Mass Assessment Score Test Sy by FDA Posted Wed 23 Mar 2011 12:00am Document issued on: March 23, 2011 For questions regarding this document contact Donna Roscoe at 301-796-6183 ( Donna.Roscoe@fda.hhs.gov ), or Marina Kondratovich at 301-796-6036 ( Marina.Kondratovich@fda.hhs.gov ). U.S. Department of Health and Hu ... Read on »
Guidance for Industry and FDA Staff: General Considerations for Animal Studies for Cardiovascular Devices by FDA Posted Sun 01 Aug 2010 9:00pm  Document issued on: July 29, 2010 For questions regarding this document, contact CAPT Victoria Hampshire, VMD, Office of Device Evaluation, at 301-796-6395 or victoria.hampshire@fda.hhs.gov .   U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radi ... Read on »
Below I've copied an article tha ... by Pam Tremble Patient Expert Posted Wed 14 Jan 2009 8:41pm Below I've copied an article that I found at Bariatric Times. This is outstanding information about the hair loss we often experience after WLS. My hair loss started at 3 months post-op, stopped at 6 months and new hair start sprouting around 9 months. Much of this information was explained to me by my PCP and I did some other research o ... Read on »
The funny logics in cardiology :The dichotomy of thrombolysis in Ischemic stroke and STEMI by Dr. Sangareddi V. Medical Doctor Posted Sun 28 Mar 2010 11:42am Thrombolytic therapy  is the specific  therapy  for Ischemic stroke ,  when administered in less than 3 hours and has proven to  save lives and brain .The only issue is , we need a 100% exclusion of hemorrhagic  stroke by a CT/MRI. The mechanism of action of thrombolytic agent is simple .It lyses cerebral thrombosis and makes way for sustained ... Read on »
Draft Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Herpes Simplex Virus Types 1 and 2 Sero by FDA Posted Mon 27 Sep 2010 9:00pm This guidance document is being distributed for comment purposes only. Document issued on: September 28, 2010 Comments and suggestions regarding this draft document should be submitted within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance.  Submi ... Read on »
Health Headlines - June 7 by Meredy Registered NurseHealth Maven Posted Thu 23 Oct 2008 2:24pm Female Hormone May Prevent Type 1 Diabetes New animal research suggests that a naturally produced estrogen hormone known as estradiol might help protect against diabetes by preventing the death of pancreatic cells critical to the production of insulin. The findings are based on work with mice and have not yet been tried in a human trial. ... Read on »
Meaningful Use Criteria by Rich Elmore Patient Expert Posted Sat 02 Jan 2010 9:10pm The Hitech Act provided for incentives to eligible professionals (EP) and hospitals that have adopted Certified EHR Technology and can demonstrate that they are meaningful users of the technology. HHS has published the proposed rule governing the criteria for me aningful use . The criteria for meaningful use will be finalized in 2010, foll ... Read on »